ASTON HEALTH AT THE ВOARD OF DIRECTORS OF THE ASSOCIATION OF INTERNATIONAL PHARMACEUTICAL MANUFACTURERS (AIPM)

Publication date: 18 december 2019

On December 11, 2019 a meeting of the Вoard of Directors of the Association of International Pharmaceutical Manufacturers (AIPM) was held in Moscow.

Anton Artyomov, CEO of Aston Health presented a report “RWE as the Basis of Health Management Platform Solution under the Federal Project Digital Technologies” with the key focus on digitalization of Russian healthcare and the need for wider use of real-world data. He suggested approving an action plan and establishing the process for expanded use of RWD / RWE in Russia as a tool for addressing clinical and research tasks.

Reference:

AIPM

The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 to represent the interests of the leading international pharmaceutical companies in Russia.

Today AIPM brings together over 60 international manufacturers, which account for more than 80% of the global pharmaceutical production and provide more than 60% of medicines circulating in the pharmaceutical sector of Russia.

Aston Health

Aston Health offers the leading-edge data and technology solutions to the Russian healthcare market players, including pharmaceutical manufacturers, regulators, medical and patient communities and professional associations.

Since 1998, the company has implemented various research and educational projects in close collaboration with industry stakeholders aimed at enhancing healthcare development in this country.